The single intravenous administration of methylene blue after traumatic brain injury diminishes neurological deficit, blood-brain barrier disruption and decrease in the expression of S100 protein in rats
Е. Е. Генрихс, E. V. Stelmashook, Д. Н. Воронков, S. V. Novikova, Olga P. Alexandrova, А. В. Федоров, Н. К. Исаев
Topics & Concepts
Traumatic brain injuryNeuroprotectionBlood–brain barrierMedicineMethylene blueEvans BlueAnesthesiaPharmacologyNeuroinflammationInflammationCentral nervous systemNeuroscienceInternal medicinePsychologyChemistryBiochemistryPsychiatryCatalysisPhotocatalysisS100 Proteins and AnnexinsTraumatic Brain Injury and Neurovascular DisturbancesImmune Response and Inflammation